Drug
Crisugabalin clinical trials
Also written HSK16149.
- studies test it
- 17
- open now
- 8
- in phase 3
- 4
- first study started
- 2020
Keep track of what changes. Save the crisugabalin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Studies by the year they started
17 studies that test it; most in 2025 (4)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 6
- Phase 3
- 4
- Phase 4
- 2
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 7
Haisco Pharmaceutical Group Co., Ltd. (10) · Guangdong Provincial People's Hospital (1) · The First Affiliated Hospital with Nanjing Medical University (1) · Tang-Du Hospital (1) · Beijing Friendship Hospital (1) · Beijing Tiantan Hospital (1) · Anhui Medical University (1) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses crisugabalin is read from its arms, and is right about nine times in ten.
Testing it · 17
- Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Exploratory TrialNot yet recruitingPhase 4Tang-Du HospitalNCT07699770Written as Crisugabalin
- Novel Calcium Channel Modulators in RLS and Variants: Efficacy & SafetyRecruitingPhase 1Beijing Friendship HospitalNCT07453862Written as Crisugabalin
- The Efficacy and Safety of Pregabalin and Crisugabalin in Patients With FibromyalgiaRecruitingNot applicableBeijing Tiantan HospitalNCT07196657Written as Crisugabalin
- Prospective Clinical Trial of Crisugabalin Capsules in the Treatment of Generalized Anxiety DisorderRecruitingPhase 2Anhui Medical UniversityNCT07330648Written as Crisugabalin 20mg bid
- Crisugabalin for Radiotherapy-Related Neuropathic PainRecruitingPhase 2Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNCT06766916Written as Crisugabalin
- Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain Who Had an Inadequate Response to PregabalinRecruitingPhase 2Haisco Pharmaceutical Group Co., Ltd.NCT06490484Written as HSK16149 20mg BID
- Efficacy and Safety of HSK16149 Capsule in the Treatment of Moderate and Severe Central Neuropathic Pain in ChinaNot yet recruitingPhase 3Haisco Pharmaceutical Group Co., Ltd.NCT06422117Written as HSK16149 20mg-40mg BID
- To Evaluate the Efficacy and Safety of HSK16149 With L-carnitine in Diabetic Peripheral Neuralgia Patients in ChinaRecruitingNot applicableHaisco Pharmaceutical Group Co., Ltd.NCT06122012Written as HSK16149 20mg BID
- EFficacy and safEty of cRisugabalin on nocipLastic paIn in Patients With Parkinson's Disease (RELIEF-PD): a Multicentre, Double-blind, Randomised Controlled TrialActive, not recruitingPhase 4Guangdong Provincial People's HospitalNCT07483398Written as Crisugabalin
- Real-World Study of Crisugabalin(HSK16149) for the Treatment of RosaceaCompletedNot applicableThe First Affiliated Hospital with Nanjing Medical UniversityNCT07606820Written as Crisugabalin(HSK16149)20mg BID
- To Evaluate the Long-term Safety and Efficacy of HSK16149 in Chinese Patients With Peripheral NeuralgiaCompletedPhase 3Haisco Pharmaceutical Group Co., Ltd.NCT05890053Written as HSK16149 40mg BID
- To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Herpetic NeuralgiaCompletedPhase 2Haisco Pharmaceutical Group Co., Ltd.NCT05763550Written as HSK16149 20mg BID
- HSK16149 for Perioperative Analgesia in Orthopedic SurgeryCompletedPhase 2Haisco Pharmaceutical Group Co., Ltd.NCT06007066Written as HSK16149 capsule
- A Study to Evaluate the Pharmacokinetics of HSK16149 in Subjects With Renal ImpairmentCompletedPhase 1Haisco Pharmaceutical Group Co., Ltd.NCT05916573Written as HSK16149
- To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Postherpetic NeuralgiaCompletedPhase 3Haisco Pharmaceutical Group Co., Ltd.NCT05140863Written as HSK16149 20mg BID
- A Study Evaluating Drug-Drug Interaction (DDI) Between HSK16149 Capsules and Metformin Hydrochloride TabletsStatus unknownPhase 1Haisco Pharmaceutical Group Co., Ltd.NCT04841720Written as HSK16149
- To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic PainStatus unknownPhase 2/3Haisco Pharmaceutical Group Co., Ltd.NCT04647773Written as HSK16149 20mg BID
Codes
What other systems call crisugabalin · ClinicalTrials.gg INT017641
- UNII (FDA) Q3MK7E8686CRISUGABALINConfirmed FDA, Wikidata
- Wikidata Q123474384crisugabalinConfirmed FDA, Wikidata
- NCI Thesaurus C199029CrisugabalinOne source FDA
- DrugBank DB19300One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | Q3MK7E8686 | CRISUGABALIN | Confirmed FDA, Wikidata |
| Wikidata | Q123474384 | crisugabalin | Confirmed FDA, Wikidata |
| NCI Thesaurus | C199029 | Crisugabalin | One source FDA |
| DrugBank | DB19300 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.